Another AIP variant, a T171I missense mutation, was found in three patients with pituitary adenoma and was associated with decreased expression of Sstr2 (somatostatin receptor 2), which is needed for responsiveness to somatostatin analogs (78). Here, SSTR2 is linked to pituitary gland adenoma.